查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813448

2032 年传导神经监测市场预测：按产品类型、来源类型、应用、最终用户和地区进行的全球分析

Conductive Neuromonitoring Market Forecasts to 2032 - Global Analysis By Product Type, Source Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球传导神经监测市场预计在 2025 年达到 3.748 亿美元，到 2032 年将达到 6.058 亿美元，预测期内的复合年增长率为 7.1%。

传导神经监测是利用电生理技术即时评估神经通路的完整性，该技术测量中枢和周围神经系统的电传导。它常用于外科手术过程中检测潜在的神经病变，利用体感诱发电位 (SSEP)、运动诱发电位 (MEP) 和肌电图 (EMG) 等技术。这种方法透过提供持续的功能状态回馈，使临床医生能够识别和预防术中神经损伤，从而提高患者安全性和手术效果。

神经系统疾病和慢性疾病的盛行率不断上升

糖尿病和心血管疾病等慢性疾病常常导致需要手术干预的併发症，因此即时神经监测至关重要。传导性神经监测技术正越来越多地被整合到外科手术工作流程中，以最大限度地减少术后残疾并改善患者预后。此外，主要经济体的人口老化也导致神经相关手术数量不断增加，进一步推动了市场成长。神经诊断工具与先进监测系统的整合也推动了该领域的技术创新。

设备和程序高成本

传导性神经监测系统的实施和维护成本高昂，需要复杂的硬体、专有软体和熟练的人员。医院和外科中心通常面临预算限制，这限制了该技术的采用，尤其是在发展中地区。耗材、校准和定期升级的成本也加重了财务负担。此外，保险报销方面的挑战以及神经监测服务缺乏全民覆盖，也阻碍了小型医疗机构投资这些系统。

缺乏标准化的报销政策

随着神经监测成为复杂手术的护理标准，医疗保健提供者和行业相关人员呼吁更清晰的计费代码和报销流程。这一差距使公司能够与监管机构和医疗机构合作，建立基于价值的定价模式。新兴市场尤其成熟，可以建立结构化的报销系统来激励病患采用。此外，开发经济高效的携带式神经监测设备有助于缩小可负担性差距，扩大可近性。

外包监控服务需求不断成长

第三方供应商提供成本更低的远端监控解决方案，减少了对资本密集安装的需求。外包虽然提高了扩充性和人员配置灵活性，但也带来了与资料安全、服务可靠性和临床课责相关的风险。严重依赖外部供应商的医院可能面临维持一致品质标准的挑战。这种转变可能会崩坏传统的收益模式，并加剧服务供应商和设备製造商之间的竞争。

COVID-19的影响：

供应链中断影响了关键部件的可得性，并延迟了安装和维护计划。然而，这场危机也凸显了远端监控和远端神经病学的重要性，并刺激了无线和云端整合神经监测平台的创新。疫情后復苏时期，手术量出现反弹，促使医院优先考虑能够提高术中安全性和减少併发症的技术，从而带来了新的市场发展动能。

预计监控系统/单元部分在预测期内将占最大份额

监测系统/装置细分市场预计将在预测期内占据最大市场份额，这得益于其在术中神经生理评估中的核心作用。这些系统提供神经功能的即时回馈，使外科医生能够在复杂的手术过程中做出明智的决策。如今，先进的设备融合了人工智慧主导的讯号解读、多重模式整合和无线连接，从而提高了准确性和易用性。它们在神经外科、整形外科和心血管外科领域的广泛应用，证明了其多功能性。

预计脊椎外科手术在预测期内的复合年增长率最高

预计脊椎外科手术领域将在预测期内达到最高成长率，这得益于脊椎畸形矫正、肿瘤切除和退化性椎间盘手术的兴起。传导性神经监测在这些手术过程中对保护运动和感觉路径、降低瘫痪和神经损伤风险起着关键作用。电极设计、讯号保真度和即时分析方面的技术创新，使神经监测成为脊椎手术室的重要组成部分。外科医生和患者对神经监测在脊椎护理中益处的认识不断提高，也促进了神经监测领域的加速增长。

比最大的地区

预计北美将在预测期内占据最大的市场份额，这得益于其强大的医疗基础设施和较高的手术量。该地区受益于先进神经监测技术的早期采用以及主要设备製造商的强大影响力。优惠的报销政策和完善的临床指南进一步支持了其应用。美国和加拿大的学术机构和研究中心正在积极推动技术进步和临床检验。

复合年增长率最高的地区：

由于医疗保健覆盖范围的扩大、外科手术数量的增加以及医疗技术投资的不断增加，预计亚太地区将在预测期内实现最高的复合年增长率。中国、印度和韩国等国家正在快速实现外科基础设施的现代化，为神经监测的应用创造了肥沃的土壤。政府旨在改善神经科护理和手术安全性的措施进一步推动了市场扩张。本土製造商正凭藉针对本地需求的经济高效的解决方案进入该领域，加剧了竞争和创新。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球传导神经监测市场（依产品类型）

  • 电极
    • 皮下针电极
    • 表面电极
    • 皮层电图 (ECoG) 电极
  • 监测系统/单位
    • 脑电图（EEG）设备
    • 肌电图（EMG）设备
    • 诱发电位（EP）系统
      • 体感诱发电位（SSEP）
      • 运动诱发电位（MEP）
      • 脑干听觉诱发电位（BAEP）
      • 视觉诱发电位（VEP）
    • 多重模式系统
  • 配件及抛弃式用品
    • 电缆和导线
    • 导电凝胶和导电膏
    • 刺激器

6. 全球传导神经监测市场（依来源类型）

  • 内部监控
  • 外包监控

7. 全球传导神经监测市场（按应用）

  • 脊椎手术
    • 减压手术
    • 脊椎融合手术
    • 脊椎矫正
  • 神经外科
    • 脑肿瘤切除术
    • 动脉瘤夹闭术
    • 功能神经外科（DBS）
  • 血管外科
  • 耳鼻喉手术
  • 其他用途

8. 全球传导神经监测市场（依最终用户）

  • 医院
  • 门诊手术中心（ASC）
  • 专科神经内科和神经外科中心
  • 其他最终用户

9. 全球传导神经监测市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Zimmer Biomet Holdings, Inc.
  • SpecialtyCare, Inc.
  • RHONEDERM GmbH
  • NuVasive, Inc.
  • Nihon Kohden Corporation
  • NeuroWave Systems Inc.
  • Neurosign Medical
  • Natus Medical Incorporated
  • Medtronic plc
  • Magstim Company Limited
  • LivaNova PLC
  • International Medical Systems Ltd.
  • Inomed Medizintechnik GmbH
  • GE HealthCare
  • Erbe Elektromedizin GmbH
  • Dr. Langer Medical GmbH
  • Computronics Healthcare
  • Cadwell Industries, Inc.
  • Bionen Co., Ltd.
  • AD-Tech Medical Instrument Corporation
Product Code: SMRC30897

According to Stratistics MRC, the Global Conductive Neuromonitoring Market is accounted for $374.8 million in 2025 and is expected to reach $605.8 million by 2032 growing at a CAGR of 7.1% during the forecast period. Conductive neuromonitoring is the real-time assessment of neural pathway integrity using electrophysiological techniques that measure electrical conduction across the central and peripheral nervous systems. Commonly employed during surgical procedures, it utilizes modalities such as somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), and electromyography (EMG) to detect potential neural compromise. This approach enables clinicians to identify and prevent intraoperative neurological injury by providing continuous feedback on functional status, thereby enhancing patient safety and surgical outcomes.

Market Dynamics:

Driver:

Increasing prevalence of neurological and chronic disorders

Chronic disorders like diabetes and cardiovascular diseases often lead to complications requiring surgical interventions, where real-time nerve monitoring becomes critical. Conductive neuromonitoring technologies are increasingly integrated into surgical workflows to minimize postoperative deficits and enhance patient outcomes. Moreover, aging populations across major economies are contributing to a higher volume of neuro-related procedures, further accelerating market growth. The convergence of neurodiagnostic tools with advanced monitoring systems is also fostering innovation in this space.

Restraint:

High cost of equipment and procedures

Conductive neuromonitoring systems involve sophisticated hardware, proprietary software, and skilled personnel, making them expensive to deploy and maintain. Hospitals and surgical centers often face budget constraints, limiting the adoption of these technologies, especially in developing regions. The cost of consumables, calibration, and periodic upgrades adds to the financial burden. Additionally, reimbursement challenges and lack of universal coverage for neuromonitoring services discourage smaller facilities from investing in these systems.

Opportunity:

Lack of standardized reimbursement policies

As neuromonitoring becomes a standard of care in complex surgeries, healthcare providers and industry players are pushing for clearer billing codes and insurance coverage. This gap allows companies to collaborate with regulatory bodies and medical associations to establish value-based pricing models. Emerging markets, in particular, are ripe for structured reimbursement systems that can incentivize adoption. Furthermore, the development of cost-effective, portable neuromonitoring units may help bridge affordability gaps and expand access.

Threat:

Growing demand for outsourced monitoring services

Third-party providers offer remote monitoring solutions at lower costs, reducing the need for capital-intensive installations. While outsourcing improves scalability and staffing flexibility, it also introduces risks related to data security, service reliability, and clinical accountability. Hospitals relying heavily on external vendors may face challenges in maintaining consistent quality standards. This shift could potentially disrupt traditional revenue models and intensify competition among service providers and device manufacturers.

Covid-19 Impact:

Supply chain interruptions affected the availability of critical components, delaying installations and maintenance schedules. However, the crisis also underscored the importance of remote monitoring and tele-neurology, prompting innovation in wireless and cloud-integrated neuromonitoring platforms. Post-pandemic recovery has seen a rebound in surgical volumes, with hospitals prioritizing technologies that enhance intraoperative safety and reduce complications, thereby revitalizing market momentum.

The monitoring systems/units segment is expected to be the largest during the forecast period

The monitoring systems/units segment is expected to account for the largest market share during the forecast period due to its central role in intraoperative neurophysiological assessments. These systems offer real-time feedback on nerve function, enabling surgeons to make informed decisions during complex procedures. Advanced units now incorporate AI-driven signal interpretation, multi-modality integration, and wireless connectivity, enhancing precision and usability. Their widespread adoption across neurosurgery, orthopedic, and cardiovascular disciplines underscores their versatility.

The spinal surgery segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the spinal surgery segment is predicted to witness the highest growth rate driven by the increasing number of spinal deformity corrections, tumor resections, and degenerative disc interventions. Conductive neuromonitoring plays a vital role in preserving motor and sensory pathways during these procedures, reducing the risk of paralysis or nerve damage. Innovations in electrode design, signal fidelity, and real-time analytics are making neuromonitoring indispensable in spinal operating rooms. The rising awareness among surgeons and patients about the benefits of neuromonitoring in spinal care is also contributing to its accelerated growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share attributed to its robust healthcare infrastructure and high surgical volumes. The region benefits from early adoption of advanced neuromonitoring technologies and strong presence of leading device manufacturers. Favorable reimbursement policies and well-established clinical guidelines further encourage widespread use. Academic institutions and research centers in the U.S. and Canada are actively contributing to technological advancements and clinical validation.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR propelled by expanding healthcare access, rising surgical procedures, and increasing investments in medical technology. Countries like China, India, and South Korea are rapidly modernizing their surgical infrastructure, creating fertile ground for neuromonitoring adoption. Government initiatives aimed at improving neurological care and surgical safety are further driving market expansion. Local manufacturers are entering the space with cost-effective solutions tailored to regional needs, intensifying competition and innovation.

Key players in the market

Some of the key players in Conductive Neuromonitoring Market include Zimmer Biomet Holdings, Inc., SpecialtyCare, Inc., RHONEDERM GmbH, NuVasive, Inc., Nihon Kohden Corporation, NeuroWave Systems Inc., Neurosign Medical, Natus Medical Incorporated, Medtronic plc, Magstim Company Limited, LivaNova PLC, International Medical Systems Ltd., Inomed Medizintechnik GmbH, GE HealthCare, Erbe Elektromedizin GmbH, Dr. Langer Medical GmbH, Computronics Healthcare, Cadwell Industries, Inc., Bionen Co., Ltd., and AD-Tech Medical Instrument Corporation.

Key Developments:

In July 2025, Zimmer Biomet announced a definitive agreement to acquire Monogram Technologies to expand its robotics suite with semi- and fully-autonomous solutions (deal value reported ~$177M). The release frames the acquisition as adding autonomy to Zimmer's robotics roadmap and accelerating commercialization of semi/fully autonomous joint-replacement tech.

In June 2025, LivaNova announced it had initiated a CMS reconsideration process for national Medicare coverage of VNS Therapy and later issued Q2 2025 results / guidance updates. The announcements focus on reimbursement strategy for VNS and financial performance for 2025.

In May 2025, Natus Medical Incorporated announced the launch of BrainWatch(TM), a point-of-care EEG solution designed for critical-care settings. The release explains the product positioning (POC EEG for ICU/ED), key features and Natus's commercialization plans for 2025.

Product Types Covered:

  • Electrodes
  • Monitoring Systems/Units
  • Accessories & Disposables

Source Types Covered:

  • Insourced Monitoring
  • Outsourced Monitori

Applications Covered:

  • Spinal Surgery
  • Neurosurgery
  • Vascular Surgery
  • ENT Surgery
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Neurology & Neurosurgery Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Conductive Neuromonitoring Market, By Product Type

  • 5.1 Introduction
  • 5.2 Electrodes
    • 5.2.1 Subdermal Needle Electrodes
    • 5.2.2 Surface Electrodes
    • 5.2.3 Electrocorticography (ECoG) Electrodes
  • 5.3 Monitoring Systems/Units
    • 5.3.1 Electroencephalography (EEG) Machines
    • 5.3.2 Electromyography (EMG) Machines
    • 5.3.3 Evoked Potential (EP) Systems
      • 5.3.3.1 Somatosensory Evoked Potentials (SSEPs)
      • 5.3.3.2 Motor Evoked Potentials (MEPs)
      • 5.3.3.3 Brainstem Auditory Evoked Potentials (BAEPs)
      • 5.3.3.4 Visual Evoked Potentials (VEPs)
    • 5.3.4 Multimodality Systems
  • 5.4 Accessories & Disposables
    • 5.4.1 Cables & Leads
    • 5.4.2 Conductive Gels and Pastes
    • 5.4.3 Stimulators

6 Global Conductive Neuromonitoring Market, By Source Type

  • 6.1 Introduction
  • 6.2 Insourced Monitoring
  • 6.3 Outsourced Monitoring

7 Global Conductive Neuromonitoring Market, By Application

  • 7.1 Introduction
  • 7.2 Spinal Surgery
    • 7.2.1 Decompression Surgery
    • 7.2.2 Spinal Fusion
    • 7.2.3 Scoliosis Correction
  • 7.3 Neurosurgery
    • 7.3.1 Brain Tumor Resection
    • 7.3.2 Aneurysm Clipping
    • 7.3.3 Functional Neurosurgery (DBS)
  • 7.4 Vascular Surgery
  • 7.5 ENT Surgery
  • 7.6 Other Applications

8 Global Conductive Neuromonitoring Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers (ASCs)
  • 8.4 Specialty Neurology & Neurosurgery Centers
  • 8.5 Other End Users

9 Global Conductive Neuromonitoring Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Zimmer Biomet Holdings, Inc.
  • 11.2 SpecialtyCare, Inc.
  • 11.3 RHONEDERM GmbH
  • 11.4 NuVasive, Inc.
  • 11.5 Nihon Kohden Corporation
  • 11.6 NeuroWave Systems Inc.
  • 11.7 Neurosign Medical
  • 11.8 Natus Medical Incorporated
  • 11.9 Medtronic plc
  • 11.10 Magstim Company Limited
  • 11.11 LivaNova PLC
  • 11.12 International Medical Systems Ltd.
  • 11.13 Inomed Medizintechnik GmbH
  • 11.14 GE HealthCare
  • 11.15 Erbe Elektromedizin GmbH
  • 11.16 Dr. Langer Medical GmbH
  • 11.17 Computronics Healthcare
  • 11.18 Cadwell Industries, Inc.
  • 11.19 Bionen Co., Ltd.
  • 11.20 AD-Tech Medical Instrument Corporation

List of Tables

  • Table 1 Global Conductive Neuromonitoring Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Conductive Neuromonitoring Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Conductive Neuromonitoring Market Outlook, By Electrodes (2024-2032) ($MN)
  • Table 4 Global Conductive Neuromonitoring Market Outlook, By Subdermal Needle Electrodes (2024-2032) ($MN)
  • Table 5 Global Conductive Neuromonitoring Market Outlook, By Surface Electrodes (2024-2032) ($MN)
  • Table 6 Global Conductive Neuromonitoring Market Outlook, By Electrocorticography (ECoG) Electrodes (2024-2032) ($MN)
  • Table 7 Global Conductive Neuromonitoring Market Outlook, By Monitoring Systems/Units (2024-2032) ($MN)
  • Table 8 Global Conductive Neuromonitoring Market Outlook, By Electroencephalography (EEG) Machines (2024-2032) ($MN)
  • Table 9 Global Conductive Neuromonitoring Market Outlook, By Electromyography (EMG) Machines (2024-2032) ($MN)
  • Table 10 Global Conductive Neuromonitoring Market Outlook, By Evoked Potential (EP) Systems (2024-2032) ($MN)
  • Table 11 Global Conductive Neuromonitoring Market Outlook, By Somatosensory Evoked Potentials (SSEPs) (2024-2032) ($MN)
  • Table 12 Global Conductive Neuromonitoring Market Outlook, By Motor Evoked Potentials (MEPs) (2024-2032) ($MN)
  • Table 13 Global Conductive Neuromonitoring Market Outlook, By Brainstem Auditory Evoked Potentials (BAEPs) (2024-2032) ($MN)
  • Table 14 Global Conductive Neuromonitoring Market Outlook, By Visual Evoked Potentials (VEPs) (2024-2032) ($MN)
  • Table 15 Global Conductive Neuromonitoring Market Outlook, By Multimodality Systems (2024-2032) ($MN)
  • Table 16 Global Conductive Neuromonitoring Market Outlook, By Accessories & Disposables (2024-2032) ($MN)
  • Table 17 Global Conductive Neuromonitoring Market Outlook, By Cables & Leads (2024-2032) ($MN)
  • Table 18 Global Conductive Neuromonitoring Market Outlook, By Conductive Gels and Pastes (2024-2032) ($MN)
  • Table 19 Global Conductive Neuromonitoring Market Outlook, By Stimulators (2024-2032) ($MN)
  • Table 20 Global Conductive Neuromonitoring Market Outlook, By Source Type (2024-2032) ($MN)
  • Table 21 Global Conductive Neuromonitoring Market Outlook, By Insourced Monitoring (2024-2032) ($MN)
  • Table 22 Global Conductive Neuromonitoring Market Outlook, By Outsourced Monitoring (2024-2032) ($MN)
  • Table 23 Global Conductive Neuromonitoring Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global Conductive Neuromonitoring Market Outlook, By Spinal Surgery (2024-2032) ($MN)
  • Table 25 Global Conductive Neuromonitoring Market Outlook, By Decompression Surgery (2024-2032) ($MN)
  • Table 26 Global Conductive Neuromonitoring Market Outlook, By Spinal Fusion (2024-2032) ($MN)
  • Table 27 Global Conductive Neuromonitoring Market Outlook, By Scoliosis Correction (2024-2032) ($MN)
  • Table 28 Global Conductive Neuromonitoring Market Outlook, By Neurosurgery (2024-2032) ($MN)
  • Table 29 Global Conductive Neuromonitoring Market Outlook, By Brain Tumor Resection (2024-2032) ($MN)
  • Table 30 Global Conductive Neuromonitoring Market Outlook, By Aneurysm Clipping (2024-2032) ($MN)
  • Table 31 Global Conductive Neuromonitoring Market Outlook, By Functional Neurosurgery (DBS) (2024-2032) ($MN)
  • Table 32 Global Conductive Neuromonitoring Market Outlook, By Vascular Surgery (2024-2032) ($MN)
  • Table 33 Global Conductive Neuromonitoring Market Outlook, By ENT Surgery (2024-2032) ($MN)
  • Table 34 Global Conductive Neuromonitoring Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 35 Global Conductive Neuromonitoring Market Outlook, By End User (2024-2032) ($MN)
  • Table 36 Global Conductive Neuromonitoring Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 37 Global Conductive Neuromonitoring Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 38 Global Conductive Neuromonitoring Market Outlook, By Specialty Neurology & Neurosurgery Centers (2024-2032) ($MN)
  • Table 39 Global Conductive Neuromonitoring Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.